Clinical trials
Observational Aneurysm trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 5 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 2 |
| Medtronic Neurovascular Clinical Affairs | 2 |
| TriVascular, Inc. | 2 |
| University of California, San Francisco | 2 |
| University of Virginia | 2 |
| W.L.Gore & Associates | 2 |
| Cedars-Sinai Medical Center | 1 |
| Children's Healthcare of Atlanta | 1 |
| Craig Hospital | 1 |
| Dynamic Light | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aneurysm | 33 |
| Intracranial Aneurysm | 7 |
| Aortic Aneurysm, Abdominal | 5 |
| Cerebrovascular Disorders | 3 |
| Stroke | 3 |
| Ehlers-Danlos Syndrome | 2 |
| Marfan Syndrome | 2 |
| Aortic Diseases | 1 |
| Aortic Dissection | 1 |
| Aortic Root Aneurysm | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.